Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg and placebo as maintenance therapy in patients with healed duodenal ulcers resistant to H2 -receptor antagonists
- 1 July 1999
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 13 (7) , 959-967
- https://doi.org/10.1046/j.1365-2036.1999.00569.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Famotidine for the Prevention of Gastric and Duodenal Ulcers Caused by Nonsteroidal Antiinflammatory DrugsNew England Journal of Medicine, 1996
- NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer DiseaseJAMA, 1994
- A Controlled Study of Ranitidine for the Prevention of Recurrent Hemorrhage from Duodenal UlcerNew England Journal of Medicine, 1994
- Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine.Gut, 1993
- The continuing development of gastric acid pump inhibitorsAlimentary Pharmacology & Therapeutics, 1993
- Review article: maintenance treatment with H2‐receptor antagonists for peptic ulcer diseaseAlimentary Pharmacology & Therapeutics, 1992
- OmeprazoleDigestive Diseases and Sciences, 1991
- Omeprazole provides quicker symptom relief and duodenal ulcer healing than ranitidineGastroenterology, 1990
- Ulcer Epidemiology: An Overview and Proposed Research FrameworkGastroenterology, 1989
- A Comparison of Two Different Doses of Omeprazole Versus Ranitidine in Treatment of Duodenal UlcersJournal of Clinical Gastroenterology, 1986